CNS Pharmaceuticals is a clinical pharmaceutical company focusing on developing anti-cancer drug candidates. Its lead drug candidate is Berubicin, an anthracycline used to treat glioblastoma multiforme. The company has license agreements and a collaboration agreement to aid in the development of its drug candidates.